In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Allarity Therapeutics Inc’s stock clocked out at $1.11, down -5.13% from its previous closing price of $1.17. In other words, the price has decreased by -$5.13 from its previous closing price. On the day, 1.16 million shares were traded. ALLR stock price reached its highest trading level at $1.19 during the session, while it also had its lowest trading level at $1.05.
Ratios:
To gain a deeper understanding of ALLR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.06 and its Current Ratio is at 2.06. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLR now has a Market Capitalization of 18886318 and an Enterprise Value of 631358.
Stock Price History:
The Beta on a monthly basis for ALLR is -0.15, which has changed by -0.95893455 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, ALLR has reached a high of $103.80, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 17.49%, while the 200-Day Moving Average is calculated to be -44.61%.
Shares Statistics:
It appears that ALLR traded 1.96M shares on average per day over the past three months and 1339470 shares per day over the past ten days. A total of 17.01M shares are outstanding, with a floating share count of 13.00M. Insiders hold about 23.57% of the company’s shares, while institutions hold 0.61% stake in the company. Shares short for ALLR as of 1744675200 were 1452054 with a Short Ratio of 0.74, compared to 1741910400 on 478562. Therefore, it implies a Short% of Shares Outstanding of 1452054 and a Short% of Float of 8.53.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
